文献速递乳腺乳腺X线

美国医疗补助人群中数字乳腺断层摄影用于乳腺癌筛查的价值分析

Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
PubMed 文献 · J Am Coll Radiol · 2017-01-27

本研究通过经济模型评估医疗补助参保女性每年筛查场景下数字乳腺断层摄影(DBT)的临床经济价值,比较单纯全视野数字乳腺摄影与联合DBT两种方案。

要点

  • DBT可能减少医疗补助参保女性因筛查召回而接受的额外影像与诊断服务。
  • DBT可能提高浸润性癌的早期检出,使治疗成本更低。
  • 在每例DBT报销增加37美元的情况下,模型预测每年每例节省8.14美元。

核心结论

  • 在医疗补助参保女性中采用DBT进行乳腺筛查,模型预测可减少后续诊断服务需求并提高浸润性癌早期检出,带来年度费用节省;作者认为更广泛采用DBT有助于为医疗补助计划提供价值导向的医疗并应对部分弱势人群获得预防保健的障碍与差异。

研究设计与样本

  • 经济模型分析,评估两种年度筛查乳腺摄影场景:全视野数字乳腺摄影,以及全视野数字乳腺摄影联合数字乳腺断层摄影;模型聚焦DBT价值的两个主要驱动因素:减少召回接受额外随访影像和诊断服务的女性数量,以及促进癌症在治疗成本较低的早期阶段被诊断。

诊断标准与关键数值

  • 模型预测每例DBT报销增加37美元时,每年每例节省8.14美元。
  • 模型预测平均规模医疗补助计划每年节省超过12000美元,典型州医疗补助计划每年节省高达207000美元。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Better understanding regarding the clinical-economic value of digital breast tomosynthesis (DBT) for breast cancer screening for Medicaid enrollees is needed to help inform sound, value-based decision making. The objective of this study was to conduct a clinical-economic value analysis of DBT for breast cancer screening among women enrolled in Medicaid to assess the potential clinical benefits, associated expenditures, and net budget impact of DBT.

METHODS: Two annual screening mammography scenarios were evaluated with an economic model: (1) full-field digital mammography and (2) combined full-field digital mammography and DBT. The model focused on two main drivers of DBT value: (1) capacity for DBT to reduce the number of women recalled for additional follow-up imaging and diagnostic services and (2) capacity of DBT to facilitate earlier diagnosis of cancer at earlier stages, when treatment costs are lower.

RESULTS: Model analysis results showed that the use of DBT as a mammographic screening modality by Medicaid enrollees potentially reduces the need for follow-up diagnostic services and improves the detection of invasive cancers, allowing earlier, less costly treatment. With the modest incremental reimbursement of $37 for DBT expected for a typical Medicaid claim, annual cost savings from DBT predicted by the model amounts to $8.14 per patient, potentially translating into more than $12,000 savings per year for an average-sized Medicaid plan and as much as $207,000 savings per year for a typical state Medicaid program.

CONCLUSIONS: Wider adoption of DBT presents an opportunity to deliver value-based care to Medicaid programs and to help address disparities and barriers to accessing preventive care by some of the nation's most vulnerable citizens.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Miller JD, Bonafede MM, Herschorn SD, et al. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population. J Am Coll Radiol. 2017. PMID: 28139412. doi:10.1016/j.jacr.2016.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。